Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.
about
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symportersDynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse modelDynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.
P2860
Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antagonistic effects of anti-E ...... povascular pancreatic cancers.
@ast
Antagonistic effects of anti-E ...... povascular pancreatic cancers.
@en
type
label
Antagonistic effects of anti-E ...... povascular pancreatic cancers.
@ast
Antagonistic effects of anti-E ...... povascular pancreatic cancers.
@en
prefLabel
Antagonistic effects of anti-E ...... povascular pancreatic cancers.
@ast
Antagonistic effects of anti-E ...... povascular pancreatic cancers.
@en
P2093
P2860
P1476
Antagonistic effects of anti-E ...... ypovascular pancreatic cancers
@en
P2093
Amber Martin
Cecil R Stockard
Christopher J Rigell
David A Boothman
Guihua Zhai
Heidi R Umphrey
Hyunki Kim
Long Shan Li
S Kyle Lee
Sharon L Samuel
P2860
P2888
P356
10.1007/S11307-013-0665-4
P577
2013-07-09T00:00:00Z